Article
Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers
13 Mar 2019
Abstract excerpt
The androgen receptor (AR) is commonly known as a key transcription factor in prostate cancer development, progression and therapy resistance. Genome-wide chromatin association studies revealed that transcriptional regulation by AR mainly depends on binding to distal regulatory enhancer elements that control gene expression through chromatin looping to gene promoters. Changes in the chromatin epigenetic landscape...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
